The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Sick After Eating: How Does It Compare to Wegovy?
Feeling sick after eating is a common side effect of both Mounjaro (tirzepatide) and Wegovy (semaglutide) during the early weeks of treatment. Both are GLP-1-based prescription-only weight management injections available in the UK, but they work slightly differently. This guide explains why nausea occurs with each medication, what clinical trials showed, and how to discuss side effect management with your prescriber during your tirzepatide or semaglutide treatment journey.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Mounjaro and Wegovy Cause Nausea: The Mechanism Difference
Both Mounjaro and Wegovy slow gastric emptying—how quickly food leaves your stomach—which typically causes nausea, particularly when eating larger meals or rich foods. However, they work through different hormone pathways.
Wegovy (semaglutide) is a GLP-1 receptor agonist only. The STEP clinical trials showed most participants experienced nausea as a very common side effect, particularly during the first 4–8 weeks at each dose escalation.
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist—it activates two hormone pathways simultaneously. The SURMOUNT-1 trial also showed nausea in more than 1 in 10 participants, though some clinical feedback suggests the dual mechanism may cause slightly different symptom patterns in individuals.
Neither medication is superior for managing nausea—individual responses vary significantly. Your prescriber will assess which is more suitable based on your medical history and tolerability.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Managing Nausea and When to Seek Prescriber Guidance
Nausea typically improves within the first 2–4 weeks as your body adjusts, though it may recur temporarily during dose increases. Practical strategies include eating smaller, more frequent meals; choosing bland, lower-fat foods; staying hydrated; and eating more slowly.
If nausea is severe or persistent beyond the adjustment period, contact your prescriber immediately—they may slow your dose titration, adjust timing, or discuss whether the medication is right for you. Never stop injecting without guidance. Use our GLP-1 weight loss calculator alongside prescriber conversations to understand realistic expectations and manage your treatment plan effectively.
Nausea typically improves within the first 2–4 weeks as your body adjusts, though it may recur temporarily during dose increases. Practical strategies include eating smaller, more frequent meals; choosing bland, lower-fat foods; staying hydrated; and eating more slowly.
If nausea is severe or persistent beyond the adjustment period, contact your prescriber immediately—they may slow your dose titration, adjust timing, or discuss whether the medication is right for you. Never stop injecting without guidance. Use our GLP-1 weight loss calculator alongside prescriber conversations to understand realistic expectations and manage your treatment plan effectively.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is nausea worse with Mounjaro or Wegovy?
Clinical trials show both cause nausea in similar proportions (very common side effect). Individual experience varies significantly—some tolerate one better than the other. Only a prescriber can assess which is more suitable for you following a clinical assessment and your personal medical history.
How long does feeling sick after eating last on these injections?
Nausea typically improves within 2–4 weeks as your body adjusts to each dose. It may briefly return during dose escalation. Most people find it manageable by week 5–6. If it persists beyond this, contact your prescriber—adjustment to your dose schedule may help.
Can I take anti-nausea medication with Mounjaro or Wegovy?
Discuss any anti-nausea medication (including ginger supplements or acupressure bands) with your prescriber first. Some medications may interact or mask important signals about tolerability. Your prescriber can suggest safe options tailored to your treatment plan.
What's the difference between tirzepatide and semaglutide for nausea?
Tirzepatide (Mounjaro) activates two hormone pathways (GIP + GLP-1); semaglutide (Wegovy) activates one (GLP-1 only). This dual mechanism may cause different individual responses, but clinical data shows comparable nausea rates. Your prescriber will choose based on your full health profile.
Should I stop my injection if I feel very sick after eating?
Do not stop without prescriber guidance. Severe nausea is manageable—contact your GP or prescriber immediately. They may adjust your dose schedule, recommend meal timing changes, or discuss alternative options. Stopping abruptly without support is not recommended.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.